Analysts Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) PT at $52.29
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month price […]
More Stories
Insider Selling: Vital Farms, Inc. (NASDAQ:VITL) Insider Sells $916,560.00 in Stock
Vital Farms, Inc. (NASDAQ:VITL – Get Free Report) insider Matthew Ohayer sold 24,000 shares of the firm’s stock in a...
AppLovin Co. (NASDAQ:APP) Insider Sells $5,000,040.97 in Stock
AppLovin Co. (NASDAQ:APP – Get Free Report) insider Victoria Valenzuela sold 15,971 shares of the business’s stock in a transaction...
Nutanix, Inc. (NASDAQ:NTNX) Director Sells $392,263.80 in Stock
Nutanix, Inc. (NASDAQ:NTNX – Get Free Report) Director Virginia Gambale sold 6,060 shares of the business’s stock in a transaction...
Top 10 Dive Watch for 2025
Searching for the right dive watch to accompany you or enhance your style during water activities in 2025? Trust dive...
Easterly Government Properties, Inc. (NYSE:DEA) CEO Buys $109,100.00 in Stock
Easterly Government Properties, Inc. (NYSE:DEA – Get Free Report) CEO Darrell W. Crate purchased 10,000 shares of the business’s stock...
Insider Buying: Calian Group Ltd. (TSE:CGY) Director Purchases 500 Shares of Stock
Calian Group Ltd. (TSE:CGY – Get Free Report) Director George Brian Weber acquired 500 shares of the company’s stock in...